Literature DB >> 1847601

Cortisol inhibits ACTH secretion in late-gestation fetal sheep.

C E Wood1.   

Abstract

In sheep, parturition is initiated by an increase in fetal adrenal secretion of cortisol. In term fetuses, adrenocorticotropic hormone (ACTH) secretion is increased despite increasing plasma concentrations of cortisol. The present study was performed to investigate whether fetal ACTH secretion is under negative-feedback control by cortisol. Ten chronically catheterized fetal sheep (140 days gestation) were used in this study. Five were infused with hydrocortisone sodium succinate (10 micrograms/min) and five with 0.9% physiological saline for 5 h. Fetal and maternal blood samples were drawn at 1-h intervals. Infusion of hydrocortisone sodium succinate significantly increased fetal plasma cortisol concentration from 38.2 +/- 8.4 ng/ml to mean levels between 74.6 +/- 11.6 and 88.5 +/- 4.7 ng/ml. Fetal plasma ACTH concentration was significantly decreased from 129 +/- 36 to 31 +/- 5 pg/ml after 5 h of infusion. Infusion of saline did not alter fetal plasma cortisol or ACTH concentration. Neither of the infusions significantly altered maternal plasma concentrations of ACTH or cortisol, or fetal or maternal blood gases, or plasma concentrations of sodium or potassium. With one exception, all fetuses were born alive at 145 +/- 1 and 144 +/- 1 days gestation in the saline- and hydrocortisone sodium succinate-infused groups, respectively. The results of this study demonstrate that at 140 days gestation fetal ACTH secretion is under negative-feedback control by cortisol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1847601     DOI: 10.1152/ajpregu.1991.260.2.R385

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  1 in total

1.  Effects of cortisol and estradiol on pituitary expression of proopiomelanocortin, prohormone convertase-1, prohormone convertase-2, and glucocorticoid receptor mRNA in fetal sheep.

Authors:  A C Holloway; W L Whittle; J R Challis
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.